Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company with over $140 billion in annual purchasing volume, announced a new agreement between Provista, a Vizient company, and Coral, a technology-enabled service provider focused on reducing healthcare costs through intelligent data management, pharmacy optimization, and value-driven sourcing.
Through the agreement, Coral will leverage Vizient’s industry-leading contract catalog for enhanced savings on pharmaceutical purchases for independent infusion providers.
“Community providers need more than just a contract—they need support across procurement, administration, and reimbursement,” said Jeremy Moskow, president of Coral. “Vizient brings unmatched scale and credibility in the marketplace, and through Provista, we’re empowering infusion providers with the purchasing power and tools they need to thrive. This agreement allows Coral to remain focused on delivering next-generation pharmacy cost management technology to ensure every dollar spent delivers measurable value.”
Also Read: nference & BeiGene Partner to Advance B-Cell Cancer Research
By aligning independent infusion centers under a common aggregation and steerage model, Coral will ensure that critical therapies remain accessible, affordable and sustainable in community settings.
Micah Smith, senior vice president of strategic sales at Vizient, added: “Provista has had tremendous success supporting providers in the infusion space, but providers often juggle direct contracting and manage several distributor relationships. Coral is looking to change that paradigm by creating a more aligned, efficient model: We’re excited to enable that structure for providers who choose to join Coral’s platform.”
Source: PRNewswire